The following video is part of our "Motley Fool Conversations" series, in which analyst John Reeves and advisor David Meier discuss topics across the investing world.
Johnson & Johnson is an outstanding company that should perform very well over the long run. Despite intense competition in all of its various business lines, this company has performed very well decade after decade. In some respects, Johnson and Johnson is the prototypical "built-to-last" company. The video concludes with a discussion about J&J's remarkable culture.
David Meier has no positions in the stocks mentioned above. John Reeves has no positions in the stocks mentioned above. The Motley Fool owns shares of Johnson & Johnson. Motley Fool newsletter services recommend Johnson & Johnson, Pfizer, and Teva Pharmaceutical Industries. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.